This company listing is no longer active
Incannex Healthcare Management
Management criteria checks 2/4
Incannex Healthcare's CEO is Joel Latham, appointed in Jun 2018, has a tenure of 5.5 years. total yearly compensation is A$3.03M, comprised of 27% salary and 73% bonuses, including company stock and options. directly owns 1.5% of the company’s shares, worth A$973.68K. The average tenure of the management team and the board of directors is 2.4 years and 4.3 years respectively.
Key information
Joel Latham
Chief executive officer
AU$3.0m
Total compensation
| CEO salary percentage | 27.0% |
| CEO tenure | 5.5yrs |
| CEO ownership | 1.5% |
| Management average tenure | 2.4yrs |
| Board average tenure | 4.3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | AU$3m | AU$820k | -AU$20m |
| Mar 31 2023 | n/a | n/a | -AU$19m |
| Dec 31 2022 | n/a | n/a | -AU$18m |
| Sep 30 2022 | n/a | n/a | -AU$17m |
| Jun 30 2022 | AU$2m | AU$534k | -AU$15m |
| Mar 31 2022 | n/a | n/a | -AU$14m |
| Dec 31 2021 | n/a | n/a | -AU$13m |
| Sep 30 2021 | n/a | n/a | -AU$12m |
| Jun 30 2021 | AU$636k | AU$279k | -AU$11m |
| Dec 31 2020 | n/a | n/a | -AU$6m |
| Sep 30 2020 | n/a | n/a | -AU$5m |
| Jun 30 2020 | AU$390k | AU$227k | -AU$4m |
| Dec 31 2019 | n/a | n/a | -AU$2m |
| Sep 30 2019 | n/a | n/a | -AU$2m |
| Jun 30 2019 | AU$204k | AU$170k | -AU$1m |
| Mar 31 2019 | n/a | n/a | -AU$3m |
| Dec 31 2018 | n/a | n/a | -AU$3m |
| Sep 30 2018 | n/a | n/a | -AU$3m |
| Jun 30 2018 | AU$162k | AU$121k | -AU$3m |
Compensation vs Market: Joel's total compensation ($USD2.00M) is above average for companies of similar size in the Australian market ($USD300.74K).
Compensation vs Earnings: Joel's compensation has increased whilst the company is unprofitable.
CEO
Joel Latham (33 yo)
5.5yrs
Tenure
AU$3,033,966
Compensation
Mr. Joel Bradley Latham has been Chief Executive Officer at Incannex Healthcare Limited (also known as Impression Healthcare Ltd.) since June 29, 2018, Managing Director and Executive Director since July 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 5.5yrs | AU$3.03m | 1.5% A$ 973.7k | |
| CFO & Company Secretary | 2.4yrs | AU$84.00k | no data | |
| Chief Technical Officer | 1.5yrs | AU$157.50k | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| Chief Executive Officer of IncannexTM | 4.1yrs | no data | no data | |
| VP of Clinical Operations & Member of the Advisory Board | no data | no data | no data | |
| Head of Finance | 1.3yrs | no data | no data |
2.4yrs
Average Tenure
56yo
Average Age
Experienced Management: IHL's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 4.4yrs | AU$3.03m | 1.5% A$ 973.7k | |
| Chief Scientific Officer | no data | no data | no data | |
| VP of Clinical Operations & Member of the Advisory Board | no data | no data | no data | |
| Member of the Advisory Board | no data | no data | no data | |
| Non-Executive Director | 1.5yrs | AU$175.87k | 4.22% A$ 2.7m | |
| Independent Non-Executive Chairman | 6yrs | AU$1.38m | 0.78% A$ 507.0k | |
| Independent Non-Executive Director | 5.8yrs | AU$316.23k | 1.08% A$ 700.5k | |
| Member of Medical Advisory Board | 4.3yrs | no data | no data | |
| Member of Medical Advisory Board | 3.3yrs | no data | no data | |
| Member of the Advisory Board | no data | no data | no data | |
| Non-Executive Director | 1.3yrs | AU$176.09k | 0% A$ 0 |
4.3yrs
Average Tenure
52.5yo
Average Age
Experienced Board: IHL's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/01 13:29 |
| End of Day Share Price | 2023/11/17 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Incannex Healthcare Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arron Aatkar | Edison Investment Research |
| David Joseph Storms | Stonegate Capital Partners, Inc. |